avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EMX2
|
ENSG00000170370.10 | empty spiracles homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EMX2 | hg19_v2_chr10_+_119301928_119301955 | 0.42 | 6.3e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.9 | 3.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 2.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 0.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 1.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 1.2 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.2 | 1.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.6 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.9 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 1.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 1.3 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 2.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 4.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.4 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 1.2 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.3 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.1 | 1.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 1.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 7.5 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.4 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 2.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.0 | 0.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 2.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 1.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.0 | 0.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 1.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 1.0 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0070458 | establishment of blood-nerve barrier(GO:0008065) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.0 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.1 | GO:0031296 | positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.6 | GO:0006334 | nucleosome assembly(GO:0006334) chromatin assembly(GO:0031497) nucleosome organization(GO:0034728) |
0.0 | 2.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.3 | GO:0042832 | carbohydrate mediated signaling(GO:0009756) defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 1.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 2.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 1.3 | GO:0097025 | lateral loop(GO:0043219) MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.3 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.1 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.3 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 3.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 1.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 3.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 3.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 1.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.4 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 0.9 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.3 | 1.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.2 | 0.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 2.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 0.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.2 | 1.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 0.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 2.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.3 | GO:0016295 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.1 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.3 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.0 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 2.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.4 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 1.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 3.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 1.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 1.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 1.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 2.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 3.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |